A. Fetisova

Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia

Е.I. Alexeeva, Leyla S. Namazova-Baranova, Alexandra Chomahidze et al. · Pediatric Rheumatology · 2017 · 23 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +11

Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study

M. Shingarova, T.M. Dvoryakovskaya, A. Fetisova et al. · Frontiers in Medicine · 2023 · 14 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data

T.M. Dvoryakovskaya, Ksenia Isaeva, A. Mamutova et al. · Frontiers in Pediatrics · 2023 · 13 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15